Base to Base biotech podcast 47: Accurate prostate cancer diagnosis and ocular gene therapy
Modifying CAR T-cells to kill solid tumours
New company created to tackle paediatric cerebral palsy
Strategic partnership to advance space-based life sciences research infrastructure
Tagomics publishes new approach to genome-wide epigenomic profiling
Fast-acting actin explains the survival of cancer cells
Phase 2 data for chronic inducible urticaria
Base to Base biotech podcast 28: CTPS1 and ocular therapeutics
Positive results from phase 1 Huntington’s disease trial
Potential for drug targeting BDCA2 and TACI
CCHF in the crosshairs
Kalexo Bio formed to advance siRNA therapy for cardiovascular disorders